Clinical Trials Browser

OTHER × monalizumab × 90 days × Clear all

NCT05903092 2026-03-12

MOZART

Phase 2 Suspended

Small Cell Lung Carcinoma

NCT06503614 2026-02-17

ENHANCE

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms